Form 4: Annexon EVP Michael Overdorf Reports Acquisition of Stock Options and Restricted Stock Units
SEC Form 4 Filing
Michael Overdorf, EVP & Chief Business Officer of Annexon, Inc., reports the acquisition of stock options and restricted stock units.
Summary
- On February 27, 2024, Michael Overdorf, EVP & Chief Business Officer of Annexon, Inc., acquired 44,963 restricted stock units (RSUs) and disposed of 131,542 shares of common stock.
- Overdorf also acquired options to purchase 272,575 shares of common stock at an exercise price of $2.50 on February 27, 2025.
- The RSUs vest in three equal annual installments beginning on February 27, 2026.
- The stock options vest monthly from February 27, 2025, over a four-year period.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders by slightly diluting the stock if the options are exercised and the RSUs vest.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction for RSUs and common stock. |
| 02/27/2025 | Date of earliest transaction for stock options and Vesting Commencement Date. |
| 02/27/2026 | First vesting date for 1/3rd of the RSUs. |
| 02/27/2034 | Expiration date for the stock options. |
| 03/03/2025 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.